ideology-health
  • Our Solutions
  • About Us
    • ideology-health
    Privacy Policy
    Terms of Service
    Inc. 5000

    IDEOlogy Health Ranks No. 772 on the 2025 Inc. 5000 Fastest-Growing Private Companies in America

    © 2025 IDEOlogy Health. All product names, logos, brands, trademarks and registered trademarks are property of their respective owners and their use(s) do not necessarily imply endorsement.

    H

    Dr Himisha Beltran, MD

    Medical professional dedicated to sharing knowledge and insights through educational videos.

    Dr. Himisha Beltran describes the safety of PARP inhibitors in treating BRCA2 mutations in prostate cancer (Video 3/3)

    Dr. Himisha Beltran describes the safety of PARP inhibitors in treating BRCA2 mutations in prostate cancer (Video 3/3)

    PARPi Safety in BRCA2m HSPC

    Himisha Beltran, MD
    GU Cancers
    Dr. Himisha Beltran reviews the data in PARP inhibitors for BRCA2 mutations in prostate cancer (Video 2/3)

    Dr. Himisha Beltran reviews the data in PARP inhibitors for BRCA2 mutations in prostate cancer (Video 2/3)

    PARPi in BRCA2m Prostate Cancer

    Himisha Beltran, MD
    GU Cancers
    Dr. Himisha Beltran discusses a paradigm shift for BRCA2 mutations in prostate cancer (Video 1/3)

    Dr. Himisha Beltran discusses a paradigm shift for BRCA2 mutations in prostate cancer (Video 1/3)

    PARPi in BRCA2m Prostate Cancer

    Himisha Beltran, MD
    GU Cancers